pcn poster

Posters

Psychiatric Comorbidities and Inpatient Outcomes in Epilepsy Patients During Hospitalization: An Analysis of the United States Nationwide Inpatient Sample

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. BACKGROUND: Psychiatric comorbidities in epilepsy impose significant...

12/21/2017

Proof-of-Concept Study Results of an Interactive Digital Treatment for Pediatric ADHD and Follow-Up Registration Study Design

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. OBJECTIVES: Pharmacological interventions are well established in th...

12/21/2017

Prevalence and Treatment Patterns of Opioid Use Disorder in Two Commercial Populations

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: Opioid use disorder (OUD) affects 2.5 million people in ...

12/21/2017

Prescriber`s Response to Non-Compliance Information: A Claims-Based Analysis of Patients With Serious Mental Illness

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: New technologies like digital medicine offer providers...

12/21/2017

Predictors of Achieving Remission in Schizophrenia Patients Treated With Paliperidone Palmitate 3-Month Formulation

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Pre-Operative Anxiety Management in Spine Surgery

This poster was presented at the 30th annual Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: Pre-operative anxiety is experienced by virtually all patien...

12/21/2017

Lurasidone for the Treatment of Major Depressive Disorder with Mixed Features: Do Manic Symptoms Moderate Treatment Response?

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. BACKGROUND: This post-hoc analysis evaluated whether the efficacy of...

12/21/2017

Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post-Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: Long-term remission is an important goal for patients wi...

12/21/2017

Long-Term Efficacy of Adjunctive Brexpiprazole in Major Depressive Disorder (MDD) - Pooled Analysis of Two Short-Term Placebo-Controlled Studies and of an Open-Label, Long-Term Extension Study

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Hospital Utilization Rates Following Antipsychotic Dose Reductions Among Patients With Schizophrenia

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: Tardive dyskinesia (TD), an often-irreversible movemen...

12/21/2017

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products